Q&A with Kimberly Stegmaier
Kimberly Stegmaier's research focuses on finding new therapeutic targets for children with cancer.
- Acute myeloid leukaemia
- Research
Category: Research
Bone density treatment slows progression of leukaemia
- Acute lymphoblastic leukaemia
- Media releases
Improving the “wait and see” approach to treatment for high-risk blood cancer
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.
- Myelodysplastic syndromes
- Research
Improving lymphoma outcomes with personal touch
Professor Gandhi discusses how personalised treatment is improving outcomes for people with Hodgkin lymphoma.
- Hodgkin lymphoma
Breakthrough therapy gives hope for new leukaemia treatment
- Chronic lymphocytic leukaemia
- Research
Targeting cancer ‘survival’ protein to kill cancer cells
A protein critical for the survival of many cancer cells might be the key to a new treatment for lymphoma and leukaemia patients.
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Research
A vital head start against cancer
Professor Maher Gandhi talks about improving outcomes for patients with DLBCL.
- Non-Hodgkin lymphoma
- Research